Taskinen S, Fagerholm R, Aronniemi J, Rintala R, Taskinen M (2008) Testicular tumors in children and adolescents
Zemba Cilic A, Zemba M, Cilic M, Strbe S, Ilic S, Vukojevic J, et al
Medium chain triglyceride formulation comprising transplatin as the therapeutic agent are prepared as described in Example A9 with the exception that the JNK inhibitor is replaced with transplatin
GHK-CU has also been studied for its ability to stimulate collagen synthesis, promote hair growth, and provide anti-inflammatory benefits
Anyone outside a healthy, monitored research context and especially anyone in one of the sensitive groups above sits entirely beyond the edge of what has been studied, which is exactly why a clinicians judgement, not a web page, is the right place for that decision to be made
Having just one word to describe such a wide range of potential actions is, to put it mildly, not particularly conducive to nuanced discussion